Gara Jalqabaatti › Lymphoma › Texas › Dallas
Qorannoo klinikaalii Lymphoma Dallas, TX keessatti
Qorannoo 10 Lymphoma f Dallas fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Namoota walitti qabaa jiraSadarkaa 1/2
- Baylor Scott & White Research Institute, Texas Oncology, Dallas
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Namoota walitti qabaa jiraSadarkaa 1/2
- The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Namoota walitti qabaa jiraSadarkaa 1/2
- Baylor Scott & White Health, Dallas
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
- Baylor University Medical Center, Dallas
DALY II USA/ MB-CART2019.1 for DLBCL
Namoota walitti qabaa jiraSadarkaa 2
- UT Southwestern Medical Center, Dallas
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Namoota walitti qabaa jiraSadarkaa 1/2
- Call for Information (Investigational Site 0054), Dallas
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Namoota walitti qabaa jiraQorannoo ilaalaa
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Texas(UT) Southwestern-Children's Medical Center, Dallas
A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors
Namoota walitti qabaa jiraSadarkaa 1
- UT Southwestern Medical Center, Dallas
Qorannoo Lymphoma magaalota biroo keessatti
- Houston, TXQorannoo 34
- Boston, MAQorannoo 33
- New York City, NYQorannoo 33
- Washington, DCQorannoo 23
- Baldwin Park, CAQorannoo 21
- Chicago, ILQorannoo 20
- Durham, NCQorannoo 17
- St. Louis, MOQorannoo 15
- Philadelphia, PAQorannoo 15
- Cleveland, OHQorannoo 14
- Edison, NJQorannoo 12
- Atlanta, GAQorannoo 12
Qorannoo biroo Dallas keessatti
- Saree OljooQorannoo 55
- Kansara Qara'a Non-Small CellQorannoo 52
- Kansara MetastatikiiQorannoo 42
- Cufama OnneeQorannoo 42
- Saree (Gosoota Hunda)Qorannoo 37
- Kansarii ProstateQorannoo 36
- Kansarii ColorectalQorannoo 33
- ObesityQorannoo 30
- Kansarii OvariiQorannoo 28
- Dhibee QaraQorannoo 27
- Dukkana BladderQorannoo 27
- Kansa EndometiriyaaliiQorannoo 24
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.